METROPRESS XL 2.5 TABLET

Product Description

METROPRESS XL 2.5 TABLET Extended-Release Prazosin for Effective Blood Pressure & Prostate Symptom Control

METROPRESS XL 2.5 TABLET contains Prazosin Hydrochloride 2.5 mg in an extended-release formulation. It is widely prescribed for the management of hypertension and benign prostatic hyperplasia (BPH). As a selective alpha-1 blocker, it works by relaxing blood vessels and improving urine flow, offering dual benefits in cardiovascular and urological health.

Key Benefits:

• Effectively lowers high blood pressure and reduces cardiovascular risk

• Improves urinary flow in patients with BPH by relaxing prostate and bladder muscles

• Extended-release formula ensures consistent, 24-hour symptom control

• Minimizes risks of night-time blood pressure spikes and related complications

• Well-tolerated with a favorable safety profile

Recommended Usage:
Ideal for patients with essential hypertension, resistant high blood pressure, and BPH-related urinary symptoms. Commonly used in both general practice and urology care.

Why Choose METROPRESS XL 2.5?
Manufactured with precision and quality, METROPRESS XL 2.5 offers consistent therapeutic results, making it a preferred product among pharmaceutical distributors, hospital suppliers, and bulk buyers seeking reliable cardiovascular and urological solutions.